Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
General Hepatology
6
Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019
View
General Hepatology
6
Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019
View
General Hepatology
6
Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019
View
General Hepatology
6
Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019
View
General Hepatology
6
Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019
View
General Hepatology
6
Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019
View
General Hepatology
6
Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020
